CorpDev.Org
Daily News for Dealmakers
Big Deal
EU Seeks Feedback on Merger Rules Revamp: Balancing Competition and Global Competitiveness
For seasoned CorpDev/ PE expertise: The European Commission has embarked on a landmark review of its merger control framework, launching parallel public consultations and an economic study to modernize guidelines last updated in 2004 and 2008. This...
Clearlake Capital’s $100 Billion Credit Ambition: Strategic Acquisitions and Market Volatility Reshape Private Debt Landscape
As global credit markets navigate unprecedented volatility, Clearlake Capital Group emerges as one of private equity's most aggressive consolidators, unveiling plans to triple its credit assets under management (AUM) to $100 billion within five...
Navigating the M&A Landscape in the Aftermath of Trump’s Liberation Day Tariffs
The global mergers and acquisitions market has entered its most turbulent phase in two decades following President Donald Trump's sweeping "Liberation Day" tariffs announced April 2, 2025. With deal volumes plunging to levels not seen since the...
Sunoco’s Strategic $9.1 Billion Acquisition of Parkland Reshapes North American Fuel Distribution Landscape
In a landmark transaction announced May 5, 2025, Sunoco LP has positioned itself to become the largest independent fuel distributor in the Americas through its $9.1 billion acquisition of Canadian energy giant Parkland Corporation. The...
Google’s Ad Tech Monopoly: The Road to Divestiture and Its Industry Implications
In a landmark antitrust ruling with far-reaching consequences for the digital advertising ecosystem, U.S. District Judge Leonie Brinkema has set the stage for potentially dismantling Google's $95 billion ad technology empire. The April 2025...
Top Jobs Currently Hiring
Thought Leadership
Private Equity
International
Tech, Media & Telecom
Financial Services
Health & Life Sciences
Novo Nordisk and Septerna Forge $2.2 Billion Alliance to Accelerate Next-Generation Obesity Therapeutics
Click here for seasoned global CorpDev/ M&A/ PE expertise on demand In a strategic move to consolidate its leadership in the rapidly expanding obesity drug market, Novo Nordisk announced a landmark collaboration with South San Francisco-based...
GSK’s $2 Billion Strategic Bet on Liver Disease Innovation: Reshaping the Hepatology Landscape
Click here for seasoned global CorpDev/ M&A/ PE expertise on demand In a bold move to secure leadership in the rapidly evolving hepatology sector, GSK announced a $2 billion acquisition of Boston Pharmaceuticals' efimosfermin alfa on May 14, 2025....
Bain Capital Nears $10B Pharma Services Play Amid GLP-1 Market Surge
Click here for seasoned global CorpDev/ M&A/ PE expertise on demand Deal at a Glance ⚖️ Valuation: $10B+ enterprise value 📈 Key Growth Driver: 78% CAGR in GLP-1 drug packaging since 2022 🩺 Market Position: PCI holds 22% sterile...
HistoSonics’ $2.5 Billion Strategic Crossroads: A Pivotal Moment for Non-Invasive Oncology Innovation
HistoSonics, the Johnson & Johnson-backed pioneer of histotripsy technology, stands at the center of a high-stakes acquisition battle that could redefine tumor treatment paradigms. With Medtronic, GE HealthCare, and J&J itself vying for control,...
Merck KGaA’s Strategic $3.5 Billion Play: Acquiring SpringWorks to Revitalize Oncology Ambitions
In a move signaling renewed aggression in pharmaceutical M&A, Germany's Merck KGaA stands poised to finalize its largest therapeutic acquisition in a decade with the $3.5 billion purchase of SpringWorks Therapeutics. The deal, expected to close as...
Consumer and Industrial
